{"id":4936,"date":"2025-10-27T10:13:01","date_gmt":"2025-10-27T07:13:01","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4936"},"modified":"2025-10-30T13:22:59","modified_gmt":"2025-10-30T10:22:59","slug":"avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/pt\/avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis\/","title":{"rendered":"Avidity Biosciences ser\u00e1 adquirido pela Novartis"},"content":{"rendered":"<p class=\"wp-block-paragraph\">A Avidity Biosciences, que est\u00e1 desenvolvendo uma terapia de salto do exon 44 para distrofia muscular de Duchenne, anunciou que firmou um acordo de fus\u00e3o definitivo com a Novartis AG (\u201cNovartis\u201d), que foi aprovado por unanimidade pelos Conselhos de Administra\u00e7\u00e3o de ambas as empresas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A aquisi\u00e7\u00e3o ocorrer\u00e1 ap\u00f3s a separa\u00e7\u00e3o dos programas de cardiologia de precis\u00e3o em est\u00e1gio inicial da Avidity na SpinCo, que dever\u00e1 ser uma empresa de capital aberto. A SpinCo ser\u00e1 liderada por Kathleen Gallagher, atualmente diretora de programas da Avidity, como diretora executiva. Sarah Boyce, atualmente diretora executiva da Avidity, atuar\u00e1 como presidente do conselho.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A Novartis adquirir\u00e1 os programas e o pipeline da Avidity em neuroci\u00eancia e obter\u00e1 acesso \u00e0 sua plataforma de entrega diferenciada de RNA direcionado. O acordo inclui tr\u00eas programas de desenvolvimento cl\u00ednico em est\u00e1gio avan\u00e7ado: delpacibart zotadirsen (del-zota) para o tratamento da distrofia muscular de Duchenne (DMD), delpacibart etedesiran (del-desiran) para o tratamento da distrofia miot\u00f4nica tipo 1 (DM1) e delpacibart braxlosiran (del-brax) para o tratamento da distrofia muscular facioescapulohumeral (FSHD).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Saber mais<\/strong>: <a href=\"https:\/\/dmdwarrior.com\/pt\/del-zota-dmd-rna-therapy-from-avidity-biosciences-reverses-the-progression-of-disease\/\">Terapia de RNA DMD Del-Zota a partir de Avidity Biosciences reverte a progress\u00e3o da doen\u00e7a<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Avidity Biosciences, which is developing an exon 44 skipping therapy for Duchenne muscular dystrophy, announced that it has entered into a definitive merger agreement with Novartis AG (&#8220;Novartis&#8221;) which has been unanimously approved by the Boards of Directors of both companies. The acquisition will follow the separation of Avidity&#8217;s early-stage precision cardiology programs into SpinCo, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4938,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[126,141,127,246,447],"class_list":["post-4936","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-avidity-biosciences","tag-exon-44","tag-exon-44-skipping","tag-exon-44-skipping-therapies","tag-novartis"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/4936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/comments?post=4936"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/4936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media\/4938"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media?parent=4936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/categories?post=4936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/tags?post=4936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}